Kallikrein B1 (KLKB1): The protein targeted by PPK antibodies is a serine protease involved in generating bradykinin, a peptide critical for vasodilation, pain signaling, and immune responses .
PPK Antibodies: These are immunoglobulins designed to bind KLKB1, often used in research to study proteolysis, inflammation, or therapeutic modulation of the kallikrein-kinin system .
In pharmacokinetic studies, PPK models analyze how antibodies distribute, metabolize, and interact in vivo. For anti-PD-1 mAbs (e.g., pembrolizumab), PPK models reveal covariates like albumin levels, body weight, and tumor type that influence drug clearance . While these studies focus on oncology, they highlight methodologies applicable to PPK antibody research.
Recent NIH research identified novel antibodies targeting malaria sporozoites, including MAD21-101, which binds conserved epitopes on Plasmodium falciparum. These antibodies could complement existing vaccines by targeting unexploited epitopes . While unrelated to PPK15, this work underscores antibody engineering advances relevant to infectious diseases.
The MAPK15 antibody (PA5-28587), sold by Thermo Fisher Scientific, targets mitogen-activated protein kinase 15 (MAPK15), a kinase involved in cellular stress responses . Its reactivity is confirmed in human cells (93% predicted), with recommended use in Western blotting (WB) and ELISA.
KEGG: spo:SPAC823.03
STRING: 4896.SPAC823.03.1
PPK15 antibody is a polyclonal antibody raised against Schizosaccharomyces pombe (fission yeast) PPK15 protein. According to product specifications, it is a rabbit polyclonal antibody generated using recombinant S. pombe PPK15 protein as the immunogen . This antibody recognizes the native PPK15 protein, which functions in cellular signaling pathways in fission yeast systems. When selecting this antibody for experiments, researchers should carefully consider the specific epitope recognition and validate cross-reactivity if working with related proteins or orthologous targets.
The PPK15 antibody has been primarily validated for ELISA and Western blot applications . For Western blotting, the recommended concentration range is 1.0-10 μg/ml, though optimization for specific experimental conditions is advisable. When using this antibody in these applications, researchers should include appropriate controls to ensure specificity and reliability of results. Although not explicitly validated for other techniques, researchers may test its utility in additional applications following proper validation protocols as outlined in antibody validation literature .
Proper validation should follow a multi-step approach:
Specificity testing: Perform Western blot analysis to confirm single band detection at the expected molecular weight (~74 kDa for typical target proteins)
Positive and negative controls: Include samples known to express or lack the target protein
Blocking peptide experiments: If available, use competing peptides to confirm epitope specificity
Knockout/knockdown validation: Test in systems where the target has been genetically removed or reduced
Cross-application validation: Compare results across multiple techniques (e.g., WB, ELISA, IF)
According to antibody validation literature, these steps help ensure that the observed signal is specific to the target protein and not due to non-specific binding or cross-reactivity .
Based on manufacturer specifications for similar antibodies, optimal storage conditions include:
Avoid repeated freeze-thaw cycles to maintain antibody functionality
Store in the supplied buffer containing 50% glycerol and 0.01M PBS (pH 7.4) with preservative
When working with the antibody, keep on ice and return to storage promptly
For long-term stability, consider preparing working aliquots to minimize freeze-thaw cycles
Proper storage significantly affects antibody performance and reproducibility across experiments, particularly for polyclonal antibodies that may contain diverse epitope recognition .
Essential controls include:
Positive control: Sample known to express the target protein
Negative control: Sample lacking the target protein (ideally knockout or naturally negative)
Technical control: Omitting primary antibody to assess secondary antibody specificity
Loading control: For Western blots, include housekeeping protein detection
Blocking peptide control: When available, pre-incubate antibody with immunizing peptide
These controls help distinguish between specific and non-specific signals and validate experimental results, particularly important for polyclonal antibodies which may have batch-to-batch variation .